Search:

Login | Subscribe

Home > Companies > Aortech International

Price	Market	Sector	Market Cap
182.50p (0.00p) 0.00%	AIM	Health Care and Related Services	£8.82m

Add to company folder | Print

Related Companies

FDT	4.25p	6.25%
AMS	32.25p	0.00%
AKR	8.50p	-1.45%
AP.	p
AVG	47.50p	0.00%
CTN	19.50p	0.00%
CUS	0.88p	0.00%
DSY	1.75p	0.00%
DEMG	10.25p	-2.38%
GTX	41.50p	-2.35%
HCEG	0.36p	-21.74%
IDH	198.00p	-2.22%
LID	7.75p	0.00%
MDY	30.50p	0.00%
MDW	4.88p	-2.50%
NIM	2.38p	0.00%
SUN	1.00p	0.00%
MLH	16.75p	0.00%

Commentary

Biomaterials and medical device developer

Recent Articles

New home for Pither	03/03/2008
AorTech	29/06/2004
Gibson tonic for Aortech	01/04/2004
New Issues 2003: The best new companies on the market	03/11/2003
AorTech	07/08/2002
AorTech	28/06/2002
Healthcare	01/06/2001
AorTech	23/05/2001
Oxford BioMedica defying market sentiment	12/03/2001
Take your seats on the takeover trail	01/03/2001
More

Recent Announcements

FDA Approval Granted to Key AorTech Customer	25/11/2008
Holding(s) in Company	30/09/2008
Annual Report and Accounts	19/09/2008
Holding(s) in Company	12/09/2008
Holding(s) in Company	08/09/2008
Result of AGM	27/08/2008
AGM Statement	27/08/2008
Agreement	26/08/2008
AorTech Issued Patent for Bio	21/08/2008
Holding(s) in Company	06/08/2008
More

Articles from the Sector

MediLink Global UK seeks China growth	14/11/2008
Celsis ‘on track’	12/11/2008
Southern Cross completes refinancing	31/10/2008
‘Progress’ at CareTech	15/10/2008
Southern Cross still selling	09/10/2008
Assura in £80m funding	07/10/2008
Tristel	06/10/2008
Silver lining at AMS	06/10/2008
Medicsight	14/08/2008
Earnings rise at Southern Cross	11/08/2008
More

Financial History

Financial Year End	31/03/2004	31/03/2005	31/03/2006	31/03/2007	31/03/2008
Currency	GBP	GBP	GBP	GBP	GBP
Turnover	0.36	0.14	1.42	0.28	1.48
Operating Profit	-2.20	-2.08	-0.67	-2.23	-1.37
Pretax Profit	-1.45	-1.87	-0.52	-2.12	-1.16
Earnings After Tax	0.53	-1.87	-0.52	-2.12	-1.16
Profit Available For Dividend	0.00	0.00	0.00	0.00	0.00
Ordinary Dividends	0.00	0.00	0.00	0.00	0.00
Retained Profit	0.53	0.00	-0.52	0.00	0.00
Shareholders Funds	7.57	5.65	5.11	2.96	7.11
Net Current Assets	5.76	4.01	3.65	0.00	0.00
Adjusted Earnings Per Share Undiluted	0.00	0.00	0.00	-55.67	-25.84
Adj Earnings Per Share	0.00	0.00	0.00	-55.67	-25.84
Dividend Per Share	0.00	0.00	0.00	0.00	0.00

Chart

Click here for interactive charting

Company Details
Address	Prestige Travel Suite, Barclays Bank House, 81-83 Victoria Road, Surbiton, KT6 4NS
Telephone
Fax	020 8399 3897
Executives
Chairman	Jon Pither (0.00% holding)
Chief Executive	Frank Maguire (0.00% holding)
Finance Director	(0.00% holding)
Non-Exec Director	Edward McDaid (9.50% holding)
Main Shareholders
	ISIS Asset Management: 24.9% Melody Investments: 13.1% Caricature Investments: 11.7% Goldman Sachs: 8.9%
Advisers
Nominated Adviser	Evolution Securities
Nominated Broker	Brewin Dolphin Securities
Solicitors	Biggart Baillie
Auditors	PricewaterhouseCoopers
Registrar	Equiniti

Commentary
Biomaterials and medical device developer
Company Data
Code	AOR
Sedol	GB00333605
Shares In Issue	4.833 m
Indices
Entry on AIM	18/12/2002
Interim Results	Dec
Final Results	Jun
Year End	Mar
Accounts Due	Sep
Int div payment	n/a
Fin div payment	n/a
Int net div per share	nil
Fin net div per share	nil
Probable CGT relief	Yes